This blog explores a number of cautionary examples, reminding that all treatments have potential harms. We should consider the evidence not just about whether a treatment works, but whether it is safe. This is the third blog of our special series on Evidently Cochrane: “Oh, really?” 12 things to help you question health advice.
Sarah Chapman looks at Cochrane evidence on the benefits and harms of pregabalin for neuropathic pain and reflects on experience of finding a balance between them.
In this guest blog, Consultant in Pain Medicine Cathy Stannard and pain researcher Andrew Moore discuss some unpalatable truths about traditional opioids for chronic non-cancer pain.
Cochrane evidence published today finds benefits and harms of HRT linked to when women start treatment. Lead researcher and cardiologist Harry Boardman explains.
New Cochrane review establishes safety of cheaper drug for a common eye disease and highlights the importance of reliable evidence